Skip to content
Est. 1998 proudly celebrating 27 years of standing behind American companies
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

Nuwellis, Inc. (NUWE)

$2.05 -6.82% NASDAQ: NUWE · 15-min delayed
  • EDEN PRAIRIE, Minnesota
  • Public · NASDAQ: NUWE
  • 38 employees
$491.9KMarket cap
$8.3MRevenue · FY2025
-$17.5MNet income
38Employees
NUWENASDAQ
2012IPO

About Nuwellis, Inc.

Nuwellis Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Reported figures

Financial summary

Revenue FY2025
$8.3M
Net income
-$17.5M
Total assets
$6.1M
Market cap
$491.9K
Gross margin
62.0%
Operating margin
-134.3%
Net margin
-211.9%

Source: SEC EDGAR · updated Jun 8, 2026

Multi-year

Revenue & profit trend

Revenue Net income
FY 2025

Financial statements

Income statement

Revenue
$8.3M
Cost of revenue
$3.1M
Gross profit
$5.1M
Operating expenses
$16.2M
Operating income
-$11.1M
Income tax
$5.0K
Net income
-$17.5M
EPS (basic)
$-25.39
EPS (diluted)
$-25.39

Balance sheet

Total assets
$6.1M
Current assets
$5.2M
Total liabilities
$3.5M
Current liabilities
$3.0M
Shareholders’ equity
$2.6M

Cash flow

Operating cash flow
-$10.8M
Investing cash flow
-$90.0K
Financing cash flow
$6.9M
Net cash flow
-$3.9M

Statements via Polygon.io (SEC filings)

NASDAQ: NUWE
$2.05 -6.82%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$2.05 $558.25

52-week range

Market cap
$491.9K
EPS (diluted)
$-25.39
Shares outstanding
240.0K
Open
Day range
Prev close
Volume
IPO date
Feb 16, 2012

Nuwellis, Inc. (NUWE) Stock Price

  • Reported a net loss of $17.5M in FY2025.
  • Revenue grew 4% from FY2021 to FY2025.
  • Gross margin of 62.0%, net margin -211.9%.
  • Trading 100% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review Nuwellis, Inc..

Write a review
Newsroom

News about Nuwellis, Inc.

News & sentiment via Polygon.io

FAQ

Nuwellis, Inc.: frequently asked questions

Is Nuwellis, Inc. an American company?

Nuwellis, Inc. is a US-based company headquartered in Eden Prairie, Minnesota, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is Nuwellis, Inc. headquartered?

Nuwellis, Inc. is headquartered in Eden Prairie, Minnesota, United States.

Is Nuwellis, Inc. publicly traded?

Yes — Nuwellis, Inc. is a publicly traded company. Its stock trades under the ticker symbol NUWE on the NASDAQ.

What does Nuwellis, Inc. do?

Nuwellis, Inc. is an American Medical Devices company in the Health & Beauty sector.

Explore

Similar companies

Browse all →